Upcoming Inflammation Conference in Boston :
http://www.bostonleaders.com/files/...ation_leaders_forum_2015__agenda_28.11.14.pdf
Invion is Talking about Athsma :
Targeting healing of the airway epithelium: more than a buffer between air and smooth muscle
Geography of the beta 2 receptor in the asthmatic airway
The opportunity to facilitate healing of the moderate to severely deranged epithelium
Study design for therapy targeting the airway; signs, symptoms, cells, and biomarkers
Dr Mitchell Glass, Executive Vice President R&D & Chief Medical Officer, Invion
Invion's biggest competitor in Lupus is talking about Lupus:
Treatment of Lupus: the physiopathology approach
The sequence: antigen presenting cells, T-cells and B-cells is valid for all auto-immune diseases. Trying to selectively deplete the body from deleterious sub-sets of B-cells led to disappointing results and to an immunosuppressant warning label by regulatory agencies
Targeting of selective auto-reactive T-cells (and therefore sub-sets of B-cells) is possible through the Altered Peptide Ligand approach that allows the modulation of specific sub-sets of T-cells inducing their anergization with consequences toward the respective auto-reactive B-cells.
Additionally, a broader approach involving auto-reactive T-cells and the control of hyperautophagy found in lupus can also lead to their anergization resulting in a depletion of the deleterious auto-reactive B-cells.
Lupuzor a modified 21-mer peptide bearing a T-cell epitope has demonstrated to be able to address both mechanisms with clinically significant results
Dr Robert Zimmer, President & Chief Scientific Officer, Immupharma
Kinda shows priorities for Invion !
- Forums
- ASX - By Stock
- IVX
- Fallen off
Fallen off, page-40
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IVX (ASX) to my watchlist
|
|||||
Last
0.4¢ |
Change
-0.001(20.0%) |
Mkt cap ! $26.41M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.4¢ | $42 | 10.34K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
25 | 10821043 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 7430737 | 28 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
25 | 10821043 | 0.004 |
21 | 14701004 | 0.003 |
5 | 4900000 | 0.002 |
8 | 13200000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 7430737 | 28 |
0.006 | 3871276 | 12 |
0.007 | 3518975 | 7 |
0.008 | 4842200 | 6 |
0.009 | 2650299 | 8 |
Last trade - 15.46pm 16/07/2024 (20 minute delay) ? |
Featured News
IVX (ASX) Chart |